Immune globulin for Measles Post-Exposure Prophylaxis

Details

• Alternative Title:
  Factsheet: Immune globulin for Measles Post-Exposure Prophylaxis
• Corporate Authors:
  National Center for Immunization and Respiratory Diseases. Division of Viral Diseases ; Centers for Disease Control and Prevention (CDC) (U.S.)
• Description:
  Immune globulin post-exposure prophylaxis (IG PEP) should not be used to control measles outbreaks, but rather to reduce the risk for infection and complications in certain vulnerable populations. Healthcare providers should provide appropriate measles PEP in coordination with local or state health departments. What is post-exposure prophylaxis for measles?
  
  Post-exposure prophylaxis (PEP) for measles, when provided promptly after initial measles exposure, may provide protection against measles infection or reduce the risk of serious illness among susceptible people. There are two types of PEP for measles: 1. MMR vaccine, if administered within 72 hours of initial measles exposure (preferred); and, 2. Immune globulin (IG), also referred to as immunoglobulin, if administered within 6 days of initial measles exposure, which is typically reserved for certain vulnerable populations.
  
  
• Content Notes:
  Publication date estimated from document properties or from webpage description.
• Subjects:
  Health Communication Immunization, Passive Immunoglobulins Measles Measles-Mumps-Rubella Vaccine Measles Vaccine Measles Virus Post-Exposure Prophylaxis Vaccination Vaccines
• Series:
  Be Ready for Measles Toolkit
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Genre:
  Guidance
• Place as Subject:
  United States
• Rights:
  Public Domain
• CIO:
  National Center for Immunization and Respiratory Diseases (NCIRD)
• Division:
  DVD - Division of Viral Diseases
• Topic:
  Diseases & Conditions
• Location:
  North America
• Pages in Document:
  3 pdf pages
• Collection(s):
  Infectious Diseases
• Main Document Checksum:
  urn:sha-512:37fa299604c03077c9a28bf124eeff17445eaf56f934caa5bb7aaea0f50bb9d915d4f06b98f373891c49189063955a07d0c3d0f4fc0c1fc972849c603c8acc86
• Download URL:
  https://stacks.cdc.gov/view/cdc/257188/cdc_257188_DS1.pdf
• File Type:
  [PDF - 234.78 KB ]